| Tag | Content |
|---|
EnhancerAtlas ID | HS133-17409 |
Organism | Homo sapiens |
Tissue/cell | melanoma |
Coordinate | chr2:105944180-105946080 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NR2F1 | MA0017.2 | chr2:105944645-105944658 | CAAAGGTCACAGG | + | 6.44 | | ZNF263 | MA0528.1 | chr2:105945990-105946011 | CCTACCCCCCACTCCTGCTCC | - | 6.49 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_12896 | chr2:105939084-105946011 | CD34_Primary_RO01480 | | SE_13366 | chr2:105937657-105948158 | CD34_Primary_RO01536 | | SE_14169 | chr2:105937916-105948605 | CD34_Primary_RO01549 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | TGAGGTTAGA TTGGTCCTGG GATTCCTGCA GTGGTGAAAA CGCTCTGCCT CCAATGCTAT 60
GACAAGAGGA CTGCCATGCA CAATCATGAG TGTAGAAGAA AAGGCAGAGT GAATGAAGGC 120
TAACAGTGGC ACCTCACCTC TCACCCAATT CAATTGTGTA ATGCAAACCT TGATGCACAT 180
AGCAAATTGG AATTCAGAAC CCACAAGTCT AACTCCAGAG TAAATCATTT GTTAGGTTAA 240
CAATTACTCA AAACATAAAA CTACATATTT TCAGAGCTGA GGGAGACCTG GCTCTACATC 300
CTCATTTATA TTTGTCAGCA ATAATTTATT GAGCACCTAC TAAATGCCAG ACCCTGTGCC 360
GGATCCTTTC CAGGCACAAT TTCTTATTAG AATTCATGTG CCTTTTCTAA TATTATCCCT 420
ATTTTGATGG AGGAATTTGA GACTCAGAAT GTCCAGCAAA TTGCCCAAAG GTCACAGGAA 480
ATGGCAGAGG CAGGATTTGA ACCCACACTC CACATTCATT ACCACCACAG AGCATCACTC 540
CCATTTCATA GATGACCTGG GGCAGGCTAG TTATGGACAG GTTCCAGCAG ATTCCAGCCA 600
GTAGACTTTC TAGTACTCCA GGCAGCGTTT TGCTACACAT CACAGAAGCA GCTGCAATGA 660
CTGTTGAGGC TGCTCGGCTG GCAGAAATGG AAGGAAAAAG AAAAGGAAGC AGCTGACCAA 720
ATGTTCCTTC TGACTGACCA TGGAACTGCG AGCTCTCAGT TGTCTGCCAG CTTCCGGCTG 780
ACCAACAGAG AGAAGCATGT CCACCATGAG AGAGTAGCAG CCACCACACA GTCCCTCTAC 840
ATTCGTTCAT CCTGACTCCA ACCAAGCCAA CACACACAAC GCAGTAGGAT CTTCCCTGCA 900
CACCTTCTCA GTGCCTTAAC TTGCCACCAC AATCACACCC GCAGCTGCCT TCCTTCCTGA 960
TAGACAAGGT GCTTGCCCAT GAGCACTTCA TCAGTGATTA AACTCTGCTC AGACATGTTT 1020
TGACCACAGC TGCGCGTGCA GTCCACGTGC AGTAAGGCCT GCTGTGTGAT CTGTGAGCCC 1080
CCATTTTTAG CAGCCAGGTA GGAGGCTTCC TGAGGGTCAC TCAACAGTCC TTGGGTAGAA 1140
GCCACGGCAG GTGCAGACAA CCGGACAGCT TCCGTGTTTA AGGATATCAA CACTTAACAC 1200
AGGGAGGCAG GCGGACTAAC TTGCACCTGC ACCTCCAGAA GGCAATGGAA AGAAAACAAT 1260
TCCACAGGGA TGACAGCTTC CAGCCCTTGA CCTGGTGCTA AAAACAGGGG CCAGGAAGCC 1320
CAGCACAGCA CTTTTCCCTA CTCCCCAACA CACCCCTGCC TACTCTCCAG ATCAGGACAA 1380
TTCAGGCCTG AGTGTGACCC GAATTTGAGC TCTCAAATCC AAAGAGCTCC CAGAAACCTC 1440
AATCACAGCG CCAAAACCAT TCCATACCAG GGATGGAGGT GCAAGTCCTT CCTGGCCCTT 1500
CTCCCCGGAA AACCCAAATC AAGGACGAGG TCTCTCAGGT CTTCCCTTGC CCTAAACACA 1560
CACGCACTCC TCACACACAA CATACACACT TGACCCCACA CCCGTGCACA CTTCATCCCA 1620
CACACACGTG AACACTTATT TGCTCACCCC AGCAGGCTAG CCGGCCCCCA CAAGGGACAG 1680
CTACCAAGTC GCACACCCGC ACACCTGCCC CCAAGTGTAT AGCCACTTGC TCCCCCCACC 1740
CCGCGTTCCA GCCCCCACTA CACCTGCCCC AGCGCACACG CACGGGCTCG CCCTCCACCC 1800
CGCCCCGCCG CCTACCCCCC ACTCCTGCTC CCCGCCCTCC TGCCCCACGC GCCCCGCGCC 1860
CTGAGCCCCG CACCCCGCGC CCCGCCGCCC TCCTCACTCA 1900
|
